A time-resolved fluorometric assay for galanin receptors

被引:15
作者
Liu, J [1 ]
Gallagher, M [1 ]
Horlick, RA [1 ]
Robbins, AK [1 ]
Webb, ML [1 ]
机构
[1] Pharmacopeia Inc, Dept Drug Discovery Res, Princeton, NJ 08543 USA
关键词
D O I
10.1177/108705719800300306
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A time-resolved fluorometric (TRF) assay was developed for human galanin receptors, subtype 1 (hGalR1), The galanin peptide was labeled with a europium chelate, Eu3+-DTTA. Ligand binding was conducted in D98/Raji cells expressing recombinant human GalR1 (hGalR1-D98/Raji) in monolayers in 96-well plates or in crude membrane preparations in 96-well filter plates. Bound ligand was quantitated by dissociation-enhanced time-resolved fluorometric measurement of Eu3+. Eu(3+-)galanin bound to hGalR1 in a saturable manner with K-d values of 2.9 +/- 0.5 nM in whole cell assays and 0.23 +/- 0.03 nM in membrane assays, The affinities of Eu3+-galanin for hGalR1 in both the whole cell and membrane assays correlated very well with those of I-125-galanin. In addition, the bound Eu3+-galanin could be competitively displaced from the receptors by galanin peptide antagonists C7, M15, M35, and M40. In hGalR1-expressing 293EBNA cells, Eu3+-galanin stimulated an increase in intracellular Ca2+ concentration with a similar EC50 value as unlabeled galanin (4.5 +/- 0.5 nM versus 4.2 +/- 0.3 nM), indicating that Eu3+ labeling did not affect the functional activity of galanin, The galanin TRF assay was employed in high throughput screening of combinatorial chemical libraries. The sensitivity of this assay is comparable with that of I-125-galanin. The advantages of this assay include elimination of radioactivity, stability, low cost, speed, and amenability for automation.
引用
收藏
页码:199 / 206
页数:8
相关论文
共 18 条
  • [1] GALANIN RECEPTORS IN A HAMSTER PANCREATIC BETA-CELL TUMOR - IDENTIFICATION AND MOLECULAR CHARACTERIZATION
    AMIRANOFF, B
    SERVIN, AL
    ROUYERFESSARD, C
    COUVINEAU, A
    TATEMOTO, K
    LABURTHE, M
    [J]. ENDOCRINOLOGY, 1987, 121 (01) : 284 - 289
  • [2] Biological characterization of neurokinin antagonists discovered through screening of a combinatorial library
    Appell, KC
    Chung, TDY
    Solly, KJ
    Chelsky, D
    [J]. JOURNAL OF BIOMOLECULAR SCREENING, 1998, 3 (01) : 19 - 27
  • [3] GALANIN AND GALANIN ANTAGONISTS - MOLECULAR AND BIOCHEMICAL PERSPECTIVES
    BARTFAI, T
    FISONE, G
    LANGEL, U
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (08) : 312 - 317
  • [4] BARTFAI T, 1993, CRIT REV NEUROBIOL, V7, P229
  • [5] New technologies for high-throughput screening
    Burbaum, JJ
    Sigal, NH
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 1997, 1 (01) : 72 - 78
  • [6] GRYNKIEWICZ G, 1985, J BIOL CHEM, V59, P4723
  • [7] MOLECULAR-CLONING OF A FUNCTIONAL HUMAN GALANIN RECEPTOR
    HABERTORTOLI, E
    AMIRANOFF, B
    LOQUET, I
    LABURTHE, M
    MAYAUX, JF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (21) : 9780 - 9783
  • [8] Time-resolved fluorometry: an overview of the labels and core technologies for drug screening applications
    Hemmila, I
    Webb, S
    [J]. DRUG DISCOVERY TODAY, 1997, 2 (09) : 373 - 381
  • [9] Hemmila I., 1994, BIOANALYTICAL APPL L
  • [10] Hemmila I, 1991, APPL FLUORESCENCE IM